Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin supplementation in vascular disease among patients with diabetic nephropathy
IRCT20200527047584N2Phase 3Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin in diabetic glomerulosclerosis and Vasculopathy, sponsored by Kashan University of Medical Sciences. Started Apr 2020; status: completed.
02
Drugs
melatonin
03
Conditions
diabetic glomerulosclerosisVasculopathy
Beyond the preview
Go deeper on IRCT20200527047584N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200527047584N2.